The level of TFAM expression was shown to correlate positively with the progression of multiple cancers; e.g., colon cancer [191], melanoma [192], hepatocellular carcinoma [193], breast cancer [194] and non-small cell lung cancer (NSCLC) [195]. The gene discussed is TFAM; the disease is non-small cell lung carcinoma.